CTI BioPharma (NASDAQ: CTIC) is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers.

Biotechnology

Education

CTI BioPharma

Adam R. Craig

Shah Nawaz Sulehria

Mary Beth Lanza

William Born

Ann Herbig

Shantha Tyavanagimatt

James K. Fong

David H. Kirske

The executive team at CTI BioPharma has a history of working in the pharmaceutical industry with a focus on biometrics and statistics. They have experience working at Sunesis Pharmaceuticals, BiPar Sciences, Geron Corp, and Pharmacyclics, Inc. They hold degrees from Stanford University and the University of Toronto in neuropsychology, statistics, and psychology.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at CTI BioPharma

Board of Directors

Leadership Team